2024 |
Derivation and validation of a predictive mortality model of in-hospital patients with Acinetobacter baumannii nosocomial infection or colonization |
Articolo in rivista |
Vai |
2024 |
Erdheim-Chester disease as complex clinical presentation and diagnosis: A case report and concise review of literature |
Articolo in rivista |
Vai |
2024 |
Do genetically determined very high and very low LDL levels contribute to Lp(a) plasma concentration? |
Articolo in rivista |
Vai |
2023 |
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia |
Articolo in rivista |
Vai |
2023 |
Statin-induced autoimmune myositis: a proposal of an "experience-based" diagnostic algorithm from the analysis of 69 patients |
Articolo in rivista |
Vai |
2023 |
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism |
Review essay (rassegna critica) |
Vai |
2022 |
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome |
Articolo in rivista |
Vai |
2022 |
Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial |
Articolo in rivista |
Vai |
2022 |
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study |
Articolo in rivista |
Vai |
2022 |
Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study |
Articolo in rivista |
Vai |
2022 |
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study |
Articolo in rivista |
Vai |
2022 |
An unusual case of chronic diarrhea: a case report |
Articolo in rivista |
Vai |
2022 |
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation |
Articolo in rivista |
Vai |
2022 |
Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients |
Articolo in rivista |
Vai |
2022 |
Comparison of two polygenic risk score to identify non-monogenic primary hypocholesterolemias in a large cohort of Italian hypocholesterolemic subjects: Polygenic hypocholesterolemias |
Articolo in rivista |
Vai |
2021 |
EFFECTIVENESS AND SAFETY OF LOMITAPIDE IN A PATIENT WITH FAMILIAL CHYLOMICRONEMIA SYNDROME |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2021 |
THE ROLE OF TRANSIENT ELASTOGRAPHY IN NAFLD |
Capitolo o Saggio |
Vai |
2021 |
EFFICACY AND SAFETY OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: THE PAN-EUROPEAN RETROSPECTIVE OBSERVATIONAL STUDY |
Articolo in rivista |
Vai |
2021 |
Resistive index of ophthalmic artery as an imaging biomarker of hypertension-related vascular and kidney damage |
Articolo in rivista |
Vai |
2021 |
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography |
Articolo in rivista |
Vai |
2021 |
Lack of phenotypic additive effect of familial defective apolipoprotein B3531 in familial hypercholesterolaemia |
Articolo in rivista |
Vai |
2021 |
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey |
Articolo in rivista |
Vai |
2021 |
Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases |
Review essay (rassegna critica) |
Vai |
2021 |
DeepSRE: Identification of sterol responsive elements and nuclear transcription factors Y proximity in human DNA by Convolutional Neural Network analysis |
Articolo in rivista |
Vai |
2020 |
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study |
Articolo in rivista |
Vai |
2020 |
MUTATION IN CANDIDATE GENES ACCOUNT FOR A SMALL MINORITY OF HYPOBETALIPOPROTEINEMIAS AND NGS ANALYSIS SUPPORT POLYGENICITY IN MUTATION-NEGATIVE PATIENTS |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2020 |
MOLECULAR CHARACTERIZATION OF PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE WITH "EXTREME LDL-C PHENOTYPES" |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2020 |
PCSK9-D374Y MEDIATED LDL-R DEGRADATION CAN BE FUNCTIONALLY INHIBITED BY EGF-A AND TRUNCATED EGF-A PEPTIDES. AN IN VITRO STUDY |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2020 |
Therapeutic options for homozygous familial hypercholesterolemia: the role of Lomitapide |
Articolo in rivista |
Vai |
2019 |
PREVALENCE OF STATIN INTOLERANCE IN A COHORT OF OUTPATIENTS IN A LIPID CLINIC |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2019 |
Resting energy expenditure and substrate oxidation in malnourished patients with type 1 glycogenosis |
Articolo in rivista |
Vai |
2019 |
Is echocardiography mandatory for patients with chronic kidney disease? |
Articolo in rivista |
Vai |
2019 |
IDENTIFICATION OF P.LEU167DEL APOE GENE MUTATION BY NEXT GENERATION SEQUENCING IN A LARGE HYPERCHOLESTEROLEMIC FAMILY |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2018 |
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred |
Articolo in rivista |
Vai |
2018 |
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study |
Articolo in rivista |
Vai |
2018 |
Liver and statins: a critical appraisal of the evidence |
Articolo in rivista |
Vai |
2018 |
Anti-PCSK9 treatment: Is ultra-low LDL always good? |
Articolo in rivista |
Vai |
2018 |
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study |
Articolo in rivista |
Vai |
2017 |
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy |
Articolo in rivista |
Vai |
2017 |
Genotypic and phenotypic characterization of patients with autosomal dominant hypercholesterolemia in sicily |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2017 |
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing |
Articolo in rivista |
Vai |
2016 |
PULMONARY EMBOLISM IN AN EMERGENCY CARE UNIT: EVALUATION OF PREDICTIVE FACTORS FROM CLINICAL HISTORY AND PHYSICAL EXAM |
Articolo in rivista |
Vai |
2016 |
Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population |
Articolo in rivista |
Vai |
2016 |
Albumin versus solvent/detergent-treated pooled plasma as replacement fluid for long-term plasma exchange therapy in a patient with primary hypertriglyceridemia and recurrent hyperlipidemic pancreatitis |
Articolo in rivista |
Vai |
2016 |
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry |
Articolo in rivista |
Vai |
2015 |
The pathophysiology of intestinal lipoprotein production |
Articolo in rivista |
Vai |
2015 |
Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia |
Articolo in rivista |
Vai |
2015 |
FISIOPATOLOGIA DELLA SINTESI DELLE LIPOPROTEINE INTESTINALI |
Articolo in rivista |
Vai |
2015 |
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome |
Articolo in rivista |
Vai |
2014 |
Intestinal epithelial HuR modulates distinct pathways of proliferation and apoptosis and attenuates small intestinal and colonic tumor development. |
Articolo in rivista |
Vai |
2013 |
REDUCTION OF CHOLESTEROL WITH NUTRACEUTICAL: RESULTS OF A DOUBLE BLIND STUDY |
Proceedings |
Vai |
2008 |
Heterogenous forms of dyslipidemiain women with polycystic ovary syndrome |
Articolo in rivista |
Vai |